CN Patent

CN114667167B — 用于治疗癌症的杂环化合物

Assigned to Atios Pharmaceutical Co ltd · Expires 2024-12-20 · 1y expired

What this patent protects

本发明涉及杂环酰胺衍生物及其在治疗和预防癌症中的用途，并且涉及包含所述衍生物的组合物及其制备方法。

USPTO Abstract

本发明涉及杂环酰胺衍生物及其在治疗和预防癌症中的用途，并且涉及包含所述衍生物的组合物及其制备方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN114667167B
Jurisdiction
CN
Classification
—
Expires
2024-12-20
Drug substance claim
No
Drug product claim
No
Assignee
Atios Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.